Login to Your Account



Targacept Wows Wall Street With Phase IIb Depression Data

By Catherine Hollingsworth


Monday, October 19, 2009
Targacept wowed analysts with newly released Phase IIb data for depression drug candidate TC-5214, making a big splash at a meeting of the Society for Neuroscience and causing shares in the company to shoot up 16percent Friday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription